| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 05/13/2008 | US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/13/2008 | US7371579 Nickel-based reagents for detecting DNA and DNA-protein contacts |
| 05/13/2008 | CA2293470C Benzimidazole derivatives |
| 05/08/2008 | WO2008034891A3 Novel genes related to glutaminyl cyclase |
| 05/08/2008 | WO2007147889A3 Preparation of telmisartan salts |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108649 Bicyclic modulators of androgen receptor function |
| 05/08/2008 | US20080108638 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1917323A1 Novel materials for organic electroluminescent devices |
| 05/07/2008 | EP1309562B1 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172968A 2-propyl-4 methyl-6-(tolimidazole-2group) benzoglioxaline salt and method for producing the same |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368467 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 05/02/2008 | WO2008052072A2 Compounds for the treatment of pain and screening methods therefor |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008019030A8 Modified azole compounds as antiinfective agents |
| 05/01/2008 | US20080103186 Novel crystalline forms of an antiviral benzimidazole compound |
| 05/01/2008 | US20080103138 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 05/01/2008 | US20080102405 Nitrogen-containing organic compound, resist composition and patterning process |
| 05/01/2008 | US20080100207 cyclopentaphenanthrene-based compound which is adapted for both dry and wet processes, and has excellent thermal stability and good charge transport and emission characteristics |
| 04/30/2008 | EP1915341A2 Compounds and compositions as tpo mimetics |
| 04/30/2008 | CN101171008A Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| 04/29/2008 | US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 04/29/2008 | US7365208 Coupling a 2-cyano-p-bromomethyl diphenyl with a 1,3-diazaspiro (4,4)nonane ring in the presence of a base, a reducing agent, and a phase transfer catalyst; angiotensin II receptor antagonist, treating cardiovascular ailments such as hypertension and heart failure |
| 04/29/2008 | US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2008046802A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096903 inhibitors of disease-related target, Heat Shock Protein 90 (HSP90); antiproliferative; 2-chloro-5'-sulfamoyladenosine analogs; derivatives of adenine and other purines; Sulfamic Acid 2-[6-amino-2-fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-purin-9-yl]-ethyl ester |
| 04/24/2008 | CA2666116A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/23/2008 | EP1914225A1 Salt molten at room temperature and display device |
| 04/23/2008 | EP1913009A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof |
| 04/23/2008 | EP1912975A1 A process for the preparation of telmisartan |
| 04/23/2008 | EP1912951A1 Preparation of 1,7` -dimethyl-2 `-propyl-2,5` -bi-1h-benzimidazole |
| 04/23/2008 | EP1615896B1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166729A Fused heterocyclic compounds |
| 04/23/2008 | CN101165062A Novel synthesis of irbesartan |
| 04/23/2008 | CN101165056A Optical activity alpha-amino acid and preparation of derivative thereof |
| 04/23/2008 | CN100383127C Process for synthesizing benzimidazole by microwave radiation |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | CA2354619C Intermediates and process for producing fluorine-containing amino acid compound by using the same |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045371A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080090890 Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments |
| 04/17/2008 | US20080090889 Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080090255 Phosphoprotein detection reagent and method of making and using the same |
| 04/17/2008 | CA2665071A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/16/2008 | EP1910385A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 04/16/2008 | EP1910384A1 Imidazo [2,1-b]thiayole derivatives as sirtuin modulating compounds |
| 04/16/2008 | EP1910362A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1910313A1 6-thioamide substituted benzimidazoles |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910311A2 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381426C Growth promotion method |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/09/2008 | EP1907366A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 04/09/2008 | EP1592671B1 N-substituted (benzoimidazole-2-yl) phenyl amines, method for their production, their use as a medicament or diagnostic agent and medicament containing said substances |
| 04/09/2008 | CN101160312A Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7354945 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/03/2008 | WO2008037381A1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | US20080079356 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/02/2008 | EP1905764A1 Substituted 2-Phenyl-benzimidazoles and their use as pharmaceuticals |
| 04/02/2008 | EP1904483A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 04/02/2008 | EP1904481A2 Process for preparing benzimidazole compounds |
| 04/02/2008 | EP1904454A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 04/02/2008 | EP1904453A2 Synergistic composition and method for inhibiting growth of microorganisms |
| 04/02/2008 | EP1904443A1 New benzoheterocyclylethylbenzamide derivatives |
| 04/02/2008 | EP1904061A1 SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS |
| 04/02/2008 | CN101155803A Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 03/27/2008 | WO2008034891A2 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |